1. Sapone A., Bai J., Ciacci C., Dolinsek J., Green P., Hadjivassiliou M., Kaukinen K., Sanders D., Schumann M., Ullrich R., Villalta D., Volta C. and Fassano A. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 2012; 10: 1-13.
  2. Mariné M., Farre C., Alsina M., Vilar P., Cortijo M., Salas A., Fernández-Bañares F., Rosinach M., Santaolalla R., Loras C., Marquès T., Cusì V., Hernández M.I., Carrasco A., Ribes J., Viver J.M. and Esteve M. The prevalence of coeliac disease is significantly higher in children compared with adults. Pharmacol. Ther. 2011; 33: 477-486.
  3. Pham-Short A., Donaghue K.C., Ambler G., Chan A.K. and Craig M.E. Short report: Epidemiology. Coeliac disease in Type 1 diabetes from 1990 to 2009: higher incidence in young children after longer diabetes duration. Diabetic Med. 2012; 29: e286-289.
  4. Murray J., McLachlan S., Adams P., Eckfeldt J., Garner C., Vulpe C., Gordeuk V., Brantner T., Leiendecker-Foster C., Killeen A., Acton R., Barcellos L., Nickerson D., Beckman K., McLaren G. and McLaren C. Association Between Celiac Disease and Iron Deficiency in Caucasians, but Not Non-Caucasians. Gastroenterol. H. 2013; 11: 808-814.
  5. Gottlieb K., Dawson J., Hussain F. and Murray J. Development of drugs for celiac disease: review of endpoints for Phase 2 and 3 trials. Gastroenterology Report. 2015; 26:1-12.
  6. Hall N., Rubin G. and Charnock A. Intentional and inadvertent non-adherence in adult coeliac disease. 2013; 68: 56-62.
  7. Dessi M., Noce A., Vergovich S., Noce G. and Daniele N. Safety Food in Celiac Disease Patients: A systematic Review. Food Nutr. Sci. 2013; 4:55-74.
  8. Lanzini A., Lanzarotto F., Villanacci V., Mora A., Bertolazzi S., Turini D., Carella G., Malagoli A., Ferrantes G., Cesana M. and Ricci C. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment. Pharmacol. Ther. 2009; 29: 1299-1308.
  9. Sharkey L.M., Corbett G., Currie E., Lee J., Sweeney N. and Woodward J.M. Optimising delivery of care in celiac disease – comparison of the benefits of repeat biopsy and serological follow-up. Pharm. and Ther. 2013; 38: 1278-1291.
  10. Lebwohl B., Granath F., Ekbom A., Smedby K., Murray J., Neugut A., Green P. and Ludvigsson F. Mucosal healing and risk for lymphoproliferative malignancy in celiac disease. Ann Intern. Med. 2013; 159: 169-175.
  11. Malamut G. and Cellier C. Refractory celiac disease. Expert Rev. Gastroenterol. Hepatol. 2014; 8(3): 323-328.
  12. Green P., Lebwohl B. and Greywoode R. Celiac Disease. Clin. Rev. Allerg. Immu. 2015; 135: 1099-106.
  13. Kerkar N., Hadzic N., Davies ET., Portmann B., Donaldson PT., Rela M., Heaton ND., Vergani D. and Mieli-Vergani G. De-novo autoimmune hepatitis after liver transplantation. 1998; 351: 409-413.
  14. Jones DE., James OF., Portmann B., Burt AD., Williams R. and Hudson M. Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. 1999; 30:53-47.
  15. Comino et al., Am J Gastroenterol (2016). Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease The American journal of gastroenterology, 111: 1456-1465
  16. Moreno et al. (2017). Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing. Gut, 66(2): 250-257